China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ)
CNY 42.92
(-3.72%)
CNY 42.92
(-3.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.22 Billion | 3 Billion | 1.87 Billion | 2.22 Billion | 1.97 Billion | 1.91 Billion |
| Net Income | 2.85 Billion | 2.49 Billion | 2.08 Billion | 1.61 Billion | 2.13 Billion | 1.47 Billion |
| Depreciation & Amortization | 853.71 Million | 522.74 Million | 476.19 Million | 391.5 Million | 334.87 Million | 349.4 Million |
| Deferred income taxes | -137.7 Million | -63.53 Million | -86.96 Million | -21.06 Million | -8.47 Million | -18.61 Thousand |
| Stock-based compensation | 82.9 Million | - | - | - | - | - |
| Change in working capital | -17.03 Million | -216.92 Million | -946.86 Million | 72.04 Million | 47 Million | 42.56 Million |
| Other non-cash items | 2.39 Billion | 203.54 Million | 260.34 Million | 142.9 Million | -549.12 Million | 44.4 Million |
| Investing Cash Flow | -821.73 Million | -2.47 Billion | -1.79 Billion | -659.34 Million | -511.37 Million | -890.73 Million |
| Investments in PPE | -857.21 Million | -951.56 Million | -870.79 Million | -621.82 Million | -535.96 Million | -600.35 Million |
| Acquisitions | 31.05 Million | -11.76 Million | -120.63 Million | -993.1 Million | 73.33 Million | -140.22 Million |
| Investment purchases | -3.18 Billion | -5.67 Billion | -5.2 Billion | -5.41 Billion | -3.8 Billion | -4.25 Billion |
| Sales/Maturities of investments | 2.22 Billion | 4.15 Billion | 4.39 Billion | 6.28 Billion | 3.76 Billion | 4.07 Billion |
| Other Investing Activities | 957.78 Million | 7.97 Million | 9.34 Million | 89.99 Million | -5.4 Million | 31.14 Million |
| Financing Cash Flow | 450 Million | -575.45 Million | -653.11 Million | -1.46 Billion | -892.16 Million | -432.64 Million |
| Debt repayment | -1.74 Billion | -462.18 Million | -28.5 Million | -1.25 Billion | -535.22 Million | -530.22 Million |
| Dividends payments | -988.34 Million | -841.85 Million | -496.13 Million | -420.92 Million | -381.77 Million | -491.26 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 3.18 Billion | 742.5 Million | -132.84 Million | 207.6 Million | 27.84 Million | 588.84 Million |
| Accounts receivables | 633.68 Million | -71.84 Million | -674.73 Million | 620.93 Million | -820.26 Million | -317.33 Million |
| Accounts payables | 315.28 Million | -21.85 Million | 458.42 Million | -241.05 Million | 774.63 Million | - |
| Inventory | -966 Million | -59.69 Million | -664.85 Million | -286.76 Million | 86.96 Million | -435.99 Million |
| Other working capital | 2.00 | -63.53 Million | -65.7 Million | -21.06 Million | 5.68 Million | 478.56 Million |
| Cash at beginning of period | 3.14 Billion | 2.4 Billion | 2.97 Billion | 2.88 Billion | 2.27 Billion | 1.68 Billion |
| Cash at end of period | 6.35 Billion | 2.36 Billion | 2.4 Billion | 2.97 Billion | 2.84 Billion | 2.27 Billion |
| Capital Expenditure | -857.21 Million | -951.56 Million | -870.79 Million | -621.82 Million | -535.96 Million | -600.35 Million |
| Effect of forex changes on cash | 5 Million | 6.34 Million | -2.3 Million | -5.12 Million | 962.4 Thousand | -346.19 Thousand |
| Net cash flow / Change in cash | 3.2 Billion | -41.92 Million | -575.4 Million | 90.91 Million | 569.25 Million | 587.52 Million |
| Free Cash Flow | 3.36 Billion | 2.05 Billion | 999.71 Million | 1.6 Billion | 1.43 Billion | 1.31 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 561.47 Million | 1.03 Billion | 1.36 Billion | 450.33 Million | 2.85 Billion | 525.47 Million |
| Depreciation & Amortization | - | 221.37 Million | 221.37 Million | 225.63 Million | 853.71 Million | -372.5 Million |
| Deferred income taxes | - | - | - | -137.7 Million | -137.7 Million | 63.3 Million |
| Stock-based compensation | - | - | - | 82.9 Million | 82.9 Million | - |
| Change in working capital | - | - | - | -332.31 Million | -17.03 Million | 437.53 Million |
| Other non-cash items | 291.35 Million | 777.91 Million | -551.99 Million | 857.5 Million | 2.39 Billion | 703.1 Million |
| Investing Cash Flow | -178.4 Million | -1.6 Billion | -275.95 Million | -1.05 Billion | -821.73 Million | -602.96 Million |
| Investments in PPE | -198.89 Million | -204.48 Million | -119.27 Million | -247.82 Million | -857.21 Million | -216.6 Million |
| Acquisitions | 5.97 Million | 65.86 Million | 1.32 Million | 13.18 Million | 31.05 Million | 13.94 Million |
| Investment purchases | -1.74 Billion | -2.95 Billion | -1.01 Billion | -2.11 Billion | -3.18 Billion | -985 Million |
| Sales/Maturities of investments | 1.86 Billion | 1.47 Billion | 857.37 Million | 1.29 Billion | 2.22 Billion | 586.69 Million |
| Other Investing Activities | -100.05 Million | 76.02 Thousand | 629.86 Thousand | 1.55 Million | 957.78 Million | -1.99 Million |
| Financing Cash Flow | -421.1 Million | -1.55 Billion | -26.33 Million | -1.2 Million | 450 Million | -543.75 Million |
| Debt repayment | -270.16 Million | -19.59 Million | -18.58 Million | -56.32 Million | -1.74 Billion | -890.39 Million |
| Dividends payments | -17.46 Million | -1.5 Billion | -20.35 Million | -988.34 Million | -988.34 Million | -23.37 Million |
| Common Stock Repurchased | 1.71 Million | -1.71 Million | - | - | - | -281.77 Thousand |
| Common Stock Issuance | - | - | - | - | - | 281.77 Thousand |
| Other Financing Activities | -133.47 Million | -1.48 Billion | -44.92 Million | 1.04 Billion | 3.18 Billion | 370.01 Million |
| Accounts receivables | - | - | - | 633.68 Million | 633.68 Million | 153.71 Million |
| Accounts payables | - | - | - | - | 315.28 Million | - |
| Inventory | - | - | - | -966 Million | -966 Million | 283.82 Million |
| Other working capital | - | - | - | - | 2.00 | - |
| Cash at beginning of period | 5.15 Billion | 7.02 Billion | 6.35 Billion | 6.61 Billion | 3.14 Billion | 5.99 Billion |
| Cash at end of period | 5.39 Billion | 5.32 Billion | 7.02 Billion | 6.35 Billion | 6.35 Billion | 6.12 Billion |
| Capital Expenditure | -198.89 Million | -204.48 Million | -119.27 Million | -247.82 Million | -857.21 Million | -216.6 Million |
| Effect of forex changes on cash | -250.84 Thousand | 851.36 Thousand | -573.04 Thousand | -592.1 Thousand | 5 Million | -107.1 Thousand |
| Net cash flow / Change in cash | 241.39 Million | -1.7 Billion | 672.77 Million | -260.69 Million | 3.2 Billion | 131.42 Million |
| Free Cash Flow | 653.93 Million | 1.38 Billion | 692.56 Million | 898.53 Million | 3.36 Billion | 1.06 Billion |
4720
039200
600889
SCCO
002168
010130